DPP4 and neoplasm: In this FIT positive sub-cohort (Figure 1A), 116/198 individuals with no neoplasia (excluding NAA) were correctly classified as negative according to sCD26 (58.59%), 87/148 (58.78%) for DPP4, and 71/146 (48.63%) for the sCD26/DPP4 ratio.